Observational studyCancer immunology, immunotherapy : CII2024

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.

Francesco Massari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.